Gail F. Schwartz

1.3k total citations
35 papers, 1.0k citations indexed

About

Gail F. Schwartz is a scholar working on Ophthalmology, Public Health, Environmental and Occupational Health and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Gail F. Schwartz has authored 35 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Ophthalmology, 10 papers in Public Health, Environmental and Occupational Health and 6 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Gail F. Schwartz's work include Glaucoma and retinal disorders (32 papers), Retinal Diseases and Treatments (15 papers) and Ocular Surface and Contact Lens (10 papers). Gail F. Schwartz is often cited by papers focused on Glaucoma and retinal disorders (32 papers), Retinal Diseases and Treatments (15 papers) and Ocular Surface and Contact Lens (10 papers). Gail F. Schwartz collaborates with scholars based in United States, Ireland and India. Gail F. Schwartz's co-authors include Harry A. Quigley, Gregory Reardon, Essy Mozaffari, Julia Williams, David Hollander, Sameer Kotak, Robert W. Platt, Brahim Bookhart, Marko A. Mychaskiw and Douglas G. Day and has published in prestigious journals such as Ophthalmology, American Journal of Ophthalmology and Investigative Ophthalmology & Visual Science.

In The Last Decade

Gail F. Schwartz

35 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gail F. Schwartz United States 15 950 380 348 96 92 35 1.0k
Minerva Granado-Casas Spain 13 77 0.1× 61 0.2× 42 0.1× 76 0.8× 7 0.1× 35 448
Annie Lacroux France 12 264 0.3× 49 0.1× 203 0.6× 7 0.1× 8 0.1× 15 525
Sirinate Krittiyawong Thailand 15 35 0.0× 22 0.1× 33 0.1× 24 0.3× 15 0.2× 50 516
Charlotte Aimee Young China 14 260 0.3× 29 0.1× 210 0.6× 5 0.1× 5 0.1× 50 434
Gregory S. Brinton United States 6 294 0.3× 36 0.1× 107 0.3× 9 0.1× 3 0.0× 7 419
Andrew Henrick United States 9 80 0.1× 40 0.1× 69 0.2× 13 0.1× 1 0.0× 10 381
Cem Köz Türkiye 8 42 0.0× 16 0.0× 44 0.1× 7 0.1× 7 0.1× 36 300
Toshika Otani Japan 10 43 0.0× 24 0.1× 43 0.1× 7 0.1× 4 0.0× 20 469
Jiun‐Lu Lin Taiwan 11 15 0.0× 24 0.1× 62 0.2× 7 0.1× 6 0.1× 23 429
Jing Zeng China 7 236 0.2× 19 0.1× 176 0.5× 10 0.1× 1 0.0× 23 348

Countries citing papers authored by Gail F. Schwartz

Since Specialization
Citations

This map shows the geographic impact of Gail F. Schwartz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gail F. Schwartz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gail F. Schwartz more than expected).

Fields of papers citing papers by Gail F. Schwartz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gail F. Schwartz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gail F. Schwartz. The network helps show where Gail F. Schwartz may publish in the future.

Co-authorship network of co-authors of Gail F. Schwartz

This figure shows the co-authorship network connecting the top 25 collaborators of Gail F. Schwartz. A scholar is included among the top collaborators of Gail F. Schwartz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gail F. Schwartz. Gail F. Schwartz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schwartz, Gail F., et al.. (2020). Characteristics and Treatment Patterns of Newly Diagnosed Open-Angle Glaucoma Patients in the United States. Ophthalmology Glaucoma. 4(2). 117–125. 11 indexed citations
2.
Pan, Qing, Henry Jampel, Pradeep Y. Ramulu, et al.. (2016). Clinical outcomes of gamma-irradiated sterile cornea in aqueous drainage device surgery: a multicenter retrospective study. Eye. 31(3). 430–436. 12 indexed citations
3.
Campbell, Joanna, et al.. (2013). Comparison of adherence and persistence with bimatoprost 0.01% versus bimatoprost 0.03% topical ophthalmic solutions. Current Medical Research and Opinion. 29(9). 1201–1209. 12 indexed citations
4.
Day, Douglas G., Thomas R. Walters, Gail F. Schwartz, et al.. (2013). Bimatoprost 0.03% preservative-free ophthalmic solution versus bimatoprost 0.03% ophthalmic solution (Lumigan) for glaucoma or ocular hypertension: a 12-week, randomised, double-masked trial. British Journal of Ophthalmology. 97(8). 989–993. 40 indexed citations
5.
6.
Reardon, Gregory, Gail F. Schwartz, & Sameer Kotak. (2010). Persistence on prostaglandin ocular hypotensive therapy: an assessment using medication possession and days covered on therapy. BMC Ophthalmology. 10(1). 5–5. 21 indexed citations
7.
Schwartz, Gail F., et al.. (2010). Patient Persistency With Topical Glaucoma Therapy is Higher With Fixed Dose Brimonidine/Timolol Than With Two-Bottle Combinations. 51(13). 185–185. 1 indexed citations
8.
Schwartz, Gail F., Jason Tan, & Sameer Kotak. (2009). Hyperemia-Associated Costs of Medication Changes in Glaucoma Patients Treated Initially With Prostaglandin Analogs. Journal of Ocular Pharmacology and Therapeutics. 25(6). 555–562. 17 indexed citations
9.
Schwartz, Gail F. & Harry A. Quigley. (2008). Adherence and Persistence with Glaucoma Therapy. Survey of Ophthalmology. 53(6). S57–S68. 239 indexed citations
10.
Schwartz, Gail F., et al.. (2008). An assessment of readiness for behaviour change in patients prescribed ocular hypotensive therapy. Eye. 23(8). 1668–1674. 8 indexed citations
11.
Schwartz, Gail F., Robert W. Platt, Gregory Reardon, & Marko A. Mychaskiw. (2007). Accounting for Restart Rates in Evaluating Persistence with Ocular Hypotensives. Ophthalmology. 114(4). 648–652. 36 indexed citations
12.
Reardon, Gregory, et al.. (2005). Cost–Effectiveness of Ocular Prostaglandins in the First Year Using Persistency on Therapy to Define Treatment Success. Investigative Ophthalmology & Visual Science. 46(13). 1961–1961. 1 indexed citations
13.
Schwartz, Gail F.. (2005). Compliance and persistency in glaucoma follow-up treatment. Current Opinion in Ophthalmology. 16(2). 114–121. 113 indexed citations
14.
Schwartz, Gail F., Gregory Reardon, & Essy Mozaffari. (2003). Persistency with latanoprost or timolol in primary open-angle glaucoma suspects. American Journal of Ophthalmology. 137(1). S13–S16. 76 indexed citations
15.
Reardon, Gregory, Gail F. Schwartz, & Essy Mozaffari. (2003). Patient Persistency with ocular prostaglandin therapy: A population-based, retrospective study. Clinical Therapeutics. 25(4). 1172–1185. 58 indexed citations
16.
Bookhart, Brahim, et al.. (2002). Population-based persistency rates for topical glaucoma medications measured with pharmacy claims data.. PubMed. 8(10 Suppl). S255–61. 58 indexed citations
17.
Schwartz, Gail F.. (2002). Measuring persistency with drug therapy in glaucoma management. The American Journal of Managed Care. 8. 11 indexed citations
18.
Stewart, William C., et al.. (2000). Therapeutic Success of Latanoprost 0.005% Compared to Brimonidine 0.2% in Patients with Open-Angle Glaucoma or Ocular Hypertension. Journal of Ocular Pharmacology and Therapeutics. 16(6). 557–564. 15 indexed citations
19.
Ramakrishnan, Rengappa, Gail F. Schwartz, R Krishnadas, P Vijayalakshmi, & Alan L. Robin. (1996). Low incidence of hypotony maculopathy following primary mitomycin C trabeculectomy in Southern India. Investigative Ophthalmology & Visual Science. 37(3). 2 indexed citations
20.
Schwartz, Gail F., et al.. (1996). Resuturing the Scleral Flap Leads to Resolution of Hypotony Maculopathy. Journal of Glaucoma. 5(4). 246???251–246???251. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Minerva Granado-Casas Breakdown of academic impact, for papers by Annie Lacroux Breakdown of academic impact, for papers by Sirinate Krittiyawong Breakdown of academic impact, for papers by Charlotte Aimee Young Breakdown of academic impact, for papers by Gregory S. Brinton Breakdown of academic impact, for papers by Andrew Henrick Breakdown of academic impact, for papers by Cem Köz Breakdown of academic impact, for papers by Toshika Otani Breakdown of academic impact, for papers by Jiun‐Lu Lin Breakdown of academic impact, for papers by Jing Zeng
Rankless by CCL
2026